Pharmaceuticals · 2012 · 69 citations · 54 references
MedicineOncologyPharmacologyCell SignalingMolecular OncologySignal TransductionBreast Cancer PharmacotherapyCancer Cell SignalingHer2-positive Breast CancerMetastatic Breast CancerMolecular ChaperonesTargeted Cancer TherapyEstrogen ReceptorsHeat Shock Protein InhibitorsHsp90 Chaperone SystemLobular NeoplasiaMetastatic Breast Cancer BiologyMetastatic Breast Cancer TreatmentMetastatic Her2-positive Breast CancerTumor Suppressor P53
Hsp90 is an abundant protein in mammalian cells. It forms several discrete complexes, each containing distinct groups of co-chaperones that assist protein folding and refolding during stress, protein transport and degradation. It interacts with a variety of proteins that play key roles in breast neoplasia including estrogen receptors, tumor suppressor p53 protein, angiogenesis transcription factor HIF-1alpha, antiapoptotic kinase Akt, Raf-1 MAP kinase and a variety of receptor tyrosine kinases of the erbB family. Elevated Hsp90 expression has been documented in breast ductal carcinomas contributing to the proliferative activity of breast cancer cells; whilst a significantly decreased Hsp90 expression has been shown in infiltrative lobular carcinomas and lobular neoplasia. Hsp90 overexpression has been proposed as a component of a mechanism through which breast cancer cells become resistant to various stress stimuli. Therefore, pharmacological inhibition of HSPs can provide therapeutic opportunities in the field of cancer treatment. 17-allylamino,17-demethoxygeldanamycin is the first Hsp90 inhibitor that has clinically been investigated in phase II trial, yielding promising results in patients with HER2-overexpressing metastatic breast cancer, whilst other Hsp90 inhibitors (retaspimycin HCL, NVP-AUY922, NVP-BEP800, CNF2024/BIIB021, SNX-5422, STA-9090, etc.) are currently under evaluation.
54
Crystal structure of an Hsp90–nucleotide–p23/Sba1 closed chaperone complex
Maruf M. U. Ali, S. Mark Roe, Cara K. Vaughan et al. · Nature · 2006 · 977 citations · Full text
Heat Shock Factor 1 Is a Powerful Multifaceted Modifier of Carcinogenesis
Chengkai Dai, Luke Whitesell, Arlin B. Rogers et al. · Cell · 2007 · 839 citations · Full text